Equine Health Market Size and Growth Forecast 2023 to 2030: Regional Developments,Research by Future
The global Equine Health Industry provides in-depth analysis and insights into a particular industry or market. These reports usually provide details about the market’s current status, future prospects, trends, challenges, competitive landscape, and opportunities.
Businesses, investors, and policymakers rely on market reports to make well-informed decisions regarding their operations and investments. Moreover, consumers can also use these reports to enhance their knowledge about the products and services available in a specific subject.
Get a sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101416
In 2023, the global equine Health Market was valued at USD 1.95 billion. According to Fortune Business Insights, the market is projected to grow at a CAGR of 6.7% during the forecast period (2024-2030) and is estimated to reach USD 3.08 billion by 2030.
Key market players included in the report:
- Zoetis Services LLC (U.S.)
- Ceva (France)
- Elanco (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Vetoquinol (France)
- Neogen Corporation (U.S.)
- Virbac (France)
- Merck & Co., Inc. (U.S.)
- Norbrook (U.K.)
- Purina Animal Nutrition LLC. (U.S.)
- Kyoritsuseiyaku Corporation (Japan)
- Equine Products UK Ltd. (U.K.)
Key components Covered in the Equine Health Market Report:
- Market size and the rate of growth
- Analysis of the competitive landscape
- SWOT analysis, which examines strengths, weaknesses, opportunities, and threats
- Identification of key market trends and drivers
- Evaluation of the regulatory environment
- Market segmentation and analysis of customer demographics
- Predictions and an outlook on the future of the market.
Buy Full Report At – https://www.fortunebusinessinsights.com/checkout-page/101416